During the first China-Asean Forum on Peaceful Use of Nuclear Technology, the China Isotope and Radiation Industry Association released a demonstration project of China-Asean peaceful Use of nuclear Technology cooperation, and HTA Co., Ltd. (referred to as HTA) "Iodine [125I] sealed seed source products and technology export" project was listed. HTA accepted the guest award at the main forum.

　　Since 2018, HTA has been working with local companies to market iodine [125I] brachytherapy in Malaysia. Since then, HTA and its partners have organized Malaysia's first iodine [125I] particle implantation therapy seminar in Malaysia, continued to carry out the marketing and publicity of particle products, and invited well-known domestic brachytherapy experts to participate in bilateral academic exchange activities and carry out on-site technical training in China and Malaysia.

　　HTA and its Malaysian partners successfully held the first iodine [125I] particle Implantation Therapy Seminar in Malaysia.

　　HTA has established a good cooperation mechanism with its Malaysian partners and has successfully obtained a trade license for iodine[125I] sealed seed sources and related products issued by the local nuclear energy regulatory authority. The two sides are continuing to promote the implementation and vigorous development of brachytherapy technology in Malaysia, constantly promoting professional and technical exchanges between the two countries, and contributing to safeguarding the lives and health of the two peoples.